MedX(R) Announces Agreement with Technology 4 Medicine

Tag : Plastic Product Development
MedX Health Corp.today announced an exclusive distribution agreement withTechnology4Medicine, a newly formed laser company based in SanClemente, CA, for the U.S. dental, dermatology, plastic surgery andanti-aging markets. Technology4Medicine will sell MedX Health'snewest laser product, Oralase(TM) immediately upon clearances fromthe Food and Drug Administration to dental offices. Oralase is alow level laser therapy (LLLT) exclusively designed for dentists toalleviate pain and accelerate tissue repair following dentalprocedures.
"This partnership fulfills a key component of our vision for growthand we are pleased to enter into this agreement with an excitingnew company such as Technology4Medicine," said Steve Guillen B.Sc.,M.B.A., President & CEO, MedX Health. "As we move forward withour business plan to become the worldwide leader in lighttechnology, MedX is committed to choosing the right partners toaccelerate product distribution while continuing to developsuperior products and explore new therapeutic opportunities forthose products. We believe that Technology4Medicine is the rightpartner to penetrate the dental and other related markets in theUnited States through their specialized, experienced sales staff."
"MedX is already well established in the rehabilitation market,offering innovative laser and light therapy products that havesuccessfully treated pain, sports injuries and other conditions,"continued Guillen. "We believe our products can offer patients withacute and chronic wounds a non-invasive, drug free solution and wefully intend to pursue these indications aggressively."
The terms of the agreement include MedX giving Technology4Medicineexclusive U.S. rights to sell Oralase and other MedX lasers thatmay be applicable in the dental, dermatology, plastic surgery andanti-aging markets. Increased levels of promotion are expected tocross over into these other large growth markets.
"This agreement helps put Technology4Medicine on the forefront oflaser product distribution," stated Jeff Jones, chief executiveofficer of Technology4Medicine. "We chose MedX as our partner tobring the many benefits of laser therapy to the US dental,aesthetic and other markets. This is a very impressive technologythat will further establish our company in the dental industry withthe best technology available. With Oralase, we believe we have awinning formula for quick uptake and use in this $1 Billionmarketplace. The application of other MedX products in key U.S.markets such as aesthetic, anti-aging and dermatology, makes this avery attractive partnership."